[DPHARMA] QoQ TTM Result on 31-Mar-2013 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
27-May-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
31-Mar-2013 [#1]
Profit Trend
QoQ- -0.03%
YoY- -5.4%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Revenue 162,404 152,048 140,724 137,091 135,311 132,969 140,215 10.26%
PBT 40,177 40,017 39,354 35,384 35,297 34,133 35,468 8.64%
Tax -6,690 -9,845 -9,526 -9,378 -9,282 -7,787 -8,043 -11.52%
NP 33,487 30,172 29,828 26,006 26,015 26,346 27,425 14.19%
-
NP to SH 33,487 30,172 29,828 26,006 26,015 26,346 27,425 14.19%
-
Tax Rate 16.65% 24.60% 24.21% 26.50% 26.30% 22.81% 22.68% -
Total Cost 128,917 121,876 110,896 111,085 109,296 106,623 112,790 9.29%
-
Net Worth 181,818 179,017 187,404 176,143 169,359 167,991 162,310 7.83%
Dividend
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Div 24,289 20,128 20,128 19,431 19,431 18,318 24,980 -1.84%
Div Payout % 72.53% 66.71% 67.48% 74.72% 74.69% 69.53% 91.09% -
Equity
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Net Worth 181,818 179,017 187,404 176,143 169,359 167,991 162,310 7.83%
NOSH 138,792 138,773 138,818 138,695 138,819 138,836 138,727 0.03%
Ratio Analysis
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
NP Margin 20.62% 19.84% 21.20% 18.97% 19.23% 19.81% 19.56% -
ROE 18.42% 16.85% 15.92% 14.76% 15.36% 15.68% 16.90% -
Per Share
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
RPS 117.01 109.57 101.37 98.84 97.47 95.77 101.07 10.22%
EPS 24.13 21.74 21.49 18.75 18.74 18.98 19.77 14.16%
DPS 17.50 14.50 14.50 14.00 14.00 13.20 18.00 -1.85%
NAPS 1.31 1.29 1.35 1.27 1.22 1.21 1.17 7.80%
Adjusted Per Share Value based on latest NOSH - 138,695
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
RPS 16.88 15.81 14.63 14.25 14.07 13.82 14.58 10.22%
EPS 3.48 3.14 3.10 2.70 2.70 2.74 2.85 14.19%
DPS 2.53 2.09 2.09 2.02 2.02 1.90 2.60 -1.79%
NAPS 0.189 0.1861 0.1948 0.1831 0.1761 0.1746 0.1687 7.84%
Price Multiplier on Financial Quarter End Date
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Date 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 -
Price 2.58 2.55 2.38 2.23 2.13 2.36 2.23 -
P/RPS 2.20 2.33 2.35 2.26 2.19 2.46 2.21 -0.30%
P/EPS 10.69 11.73 11.08 11.89 11.37 12.44 11.28 -3.50%
EY 9.35 8.53 9.03 8.41 8.80 8.04 8.87 3.56%
DY 6.78 5.69 6.09 6.28 6.57 5.59 8.07 -10.93%
P/NAPS 1.97 1.98 1.76 1.76 1.75 1.95 1.91 2.07%
Price Multiplier on Announcement Date
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Date 26/02/14 19/11/13 28/08/13 27/05/13 25/02/13 23/11/12 16/08/12 -
Price 2.60 2.56 2.44 2.51 2.17 2.28 2.38 -
P/RPS 2.22 2.34 2.41 2.54 2.23 2.38 2.35 -3.71%
P/EPS 10.78 11.77 11.36 13.39 11.58 12.01 12.04 -7.08%
EY 9.28 8.49 8.81 7.47 8.64 8.32 8.31 7.61%
DY 6.73 5.66 5.94 5.58 6.45 5.79 7.56 -7.44%
P/NAPS 1.98 1.98 1.81 1.98 1.78 1.88 2.03 -1.64%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment